Free Trial

John Wilkin Analyst Performance

Analyst at Craig Hallum

John Wilkin is a stock analyst at Craig Hallum, covering 5 publicly traded companies across a range of sectors. Over the past year, John Wilkin has issued 5 stock ratings, including and buy recommendations. While full access to John Wilkin's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights John Wilkin's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
5 Last 0 Years
Buy Recommendations
100.00% 5 Buy Ratings
Companies Covered
5 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%5 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
5 companies

John Wilkin, an analyst at Craig Hallum, currently covers 5 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
5 companies
100.0%

John Wilkin of Craig Hallum specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
2 companies
40.0%
MED PRODUCTS
1 company
20.0%
MED INSTRUMENTS
1 company
20.0%
MED - GENERIC DRG
1 company
20.0%

John Wilkin's Ratings History at Craig Hallum

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Exagen Inc. stock logo
XGN
Exagen
7/23/2025Initiated Coverage$6.94$12.00Buy
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
6/18/2025Initiated Coverage$10.14$15.00Buy
Veracyte, Inc. stock logo
VCYT
Veracyte
3/20/2025Initiated Coverage$31.78$45.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
3/17/2025Initiated Coverage$3.63$8.00Buy
Myriad Genetics, Inc. stock logo
MYGN
Myriad Genetics
2/12/2025Initiated Coverage$12.74$29.00Buy